Cargando…
Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition
Pulmonary fibrosis (PF) is a progressive and chronic lung disease characterized by excessive extracellular matrix (ECM) deposition and fibroblast proliferation. Endothelial-to-mesenchymal transition (EndMT) serves as a source of fibroblasts and contributes to PF progression. Ginsenoside Rg3 (Rg3), a...
Autores principales: | Yun, Eunsik, Kwon, Byung Su, Kim, Jongmin, Lee, Aram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405771/ https://www.ncbi.nlm.nih.gov/pubmed/37554358 http://dx.doi.org/10.1080/19768354.2023.2244549 |
Ejemplares similares
-
Ginsenoside Rg3 protects against iE-DAP–induced endothelial-to-mesenchymal transition by regulating the miR-139-5p–NF-κB axis
por: Lee, Aram, et al.
Publicado: (2020) -
Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases
por: Yun, Eunsik, et al.
Publicado: (2020) -
Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-β1/Smad Pathway
por: Guan, Sibin, et al.
Publicado: (2017) -
Ginsenoside Rg3 inhibits pulmonary fibrosis by preventing HIF-1α nuclear localisation
por: Fu, Zhuo, et al.
Publicado: (2021) -
Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial Mesenchymal Transition
por: Wang, Dingkun, et al.
Publicado: (2019)